Performance of two commercial assays for detecting hepatitis E virus RNA in acute or chronic infections
- PMID: 23515544
- PMCID: PMC3716096
- DOI: 10.1128/JCM.00661-13
Performance of two commercial assays for detecting hepatitis E virus RNA in acute or chronic infections
Abstract
We assessed the performance of the Ceeram and Altona assays, the first two commercially available hepatitis E virus (HEV) RNA assays, using serial dilutions of 4 HEV-positive reference samples (genotypes 3a, 3c, 3e, and 3f). Both assays provided good analytical sensitivity and high reproducibility for detecting genotype 3 HEV RNA.
Figures
References
-
- Hoofnagle JH, Nelson KE, Purcell RH. 2012. Hepatitis E. N. Engl. J. Med. 367:1237–1244 - PubMed
-
- Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR. 2012. Hepatitis E. Lancet 379:2477–2488 - PubMed
-
- Lu L, Li C, Hagedorn CH. 2006. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev. Med. Virol. 16:5–36 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
